KRRO-121, a potential first-in-class transformational treatment for hyperammonemia, remains on track to commence first-in-human clinical trial in ...

SGT-003 has been generally well tolerated in the Phase 1/2 INSPIRE DUCHENNE clinical trial, with 53 participants dosed as ...

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced financial results for the second quarter ended June 30, 2026.

Setidegrasib, a first-in-class KRAS G12D degrader, uses the cell’s own recycling system to destroy a key cancer driver ...

The four-star edge rusher chose the Hoosiers over Penn State, Ohio State, Michigan and Michigan State after recording 85 tackles and six sacks last season.

Here’s an early look at which quarterbacks statewide will be the best of the best in 6A Public Alabama high school football ...

Q2 2026 Earnings Call August 6, 2026 8:30 AM EDTCompany ParticipantsHarrison AaronMichael Gorenstein - President, CEO ...

Snubbing university, genetics testing for supplements, Sir Alex Ferguson and Jose Mourinho - Chris Smalling is not your ...

Overview of 5 FDA Priority Review PDUFA decision dates in September 2026, covering novel treatments in rare neurological disorders, oncology, and adolescent cardiology.

Key Points Interested in Arcturus Therapeutics Holdings Inc.? Here are five stocks we like better. ARCT-032 cystic fibrosis ...

Civil liberties groups warn that one seemingly harmless act during a police encounter could surrender your genetic identity ...

Heartland Dental, the nation's leading dental support organization, announced today that Chief Executive Officer Pat Bauer has received the 2026 Dental Titan Award, an honor for individuals whose ...